Ewing Sarcoma
USMLE Step 1 trap: Confuses Ewing sarcoma translocation t(11;22) with the Philadelphia chromosome t(9;22). Ewing sarcoma is defined by t(11;22), producing the EWS-FLI1 fusion protein.
Ewing sarcoma is a malignant bone tumor of primitive neuroectodermal origin, tested on USMLE Step 1 from multiple angles: pure recall of the t(11;22) translocation, application of imaging findings to a vignette, and passage-based reasoning where you distinguish Ewing from osteomyelitis in a sick child with a bone lesion. Students routinely mix up t(11;22) with t(9;22) — the Philadelphia chromosome of CML — and misattribute the onion-skin periosteal reaction to osteomyelitis instead of Ewing. It hits a specific demographic — children and adolescents, typically in the diaphysis of long bones — and presents with a clinical picture that can fool you into thinking infection.
The tricky part is that Ewing sarcoma is a great mimicker. Fever, leukocytosis, and elevated ESR in a child with a lytic bone lesion sounds like osteomyelitis — and that's exactly the trap the exam sets. The other major confusion point is the translocation: students often mix up t(11;22) with t(9;22), which is the Philadelphia chromosome of CML. These are completely different diseases and completely different mechanisms, but under exam pressure they blur together.
Histologically, Ewing sarcoma belongs to the small round blue cell tumor family alongside neuroblastoma, lymphoma, and rhabdomyosarcoma — knowing how to differentiate these on USMLE Step 1 matters. On imaging, onion-skin periosteal layering is the classic finding, and students frequently misattribute this to osteomyelitis rather than Ewing. Get these anchors locked in — translocation, location, imaging, mimics — and this is a reliable high-yield point.
Common misconceptions
What the exam tests
- Recognize the classic epidemiology: Ewing sarcoma presents in children and adolescents with diaphyseal bone pain, often with systemic symptoms (fever, weight loss) that mimic infection or lymphoma.
- Know that Ewing sarcoma is defined by the t(11;22) translocation producing the EWS-FLI1 fusion protein, and that the cell of origin is primitive neuroectodermal (PNET lineage), not osteoblastic.
- Identify onion-skin periosteal reaction on X-ray as characteristic of Ewing sarcoma, and recognize the histologic appearance as small round blue cells on biopsy.
- Include Ewing sarcoma in the differential when a child presents with fever, elevated ESR, leukocytosis, and a lytic diaphyseal lesion — biopsy is required to distinguish it from osteomyelitis.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →